Human Health Innovation

Boehringer Ingelheim is clear about its goals. We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. That starts with innovation.

Latest Articles on Human Health

Transforming Science: Boehringer Ingelheim Employees

Join us in person, or virtually, to meet, learn about our pipeline, network and partner!

With a pipeline of around 90 clinical and pre-clinical projects, and the potential to deliver up to 20 new therapy approvals over the next seven years, we continue our track record of long-term innovation-led performance.

Human Health Innovation

Our Innovation Strategy: how we approach research and development

Disease never rests. So neither do we. Learn about how we are driving innovation in research and development, with the patient at the core of everything with do.

BRASS, a software advancing patient safety

Human Health Innovation

Digital innovation: “Our digital pipeline is only growing”

BRASS, a software advancing patient safety and developed fully in-house, has been sold. This is proof: our digital innovations are in demand.

The rise of drug-resistant pathogens is a real threat.

Human Health Innovation

“Rapid progress towards clinical candidates”

Michel Pairet, Member of the Board of Managing Directors, explains why Boehringer Ingelheim expands its commitment to fighting drug resistant infections with a new joint venture.